Teva Shares Pop as FDA Approves Its Migraine Drug - TheStreet
U.S. FDA raises concerns over Teva's plant in China | Reuters
Teva Issues Voluntary Nationwide Recall of One Lot of Anagrelide Capsules | DAIC
Teva Pharmaceuticals USA, Inc., Issues Voluntary Nationwide Recall of Specific Lots of Fentanyl Buccal Tablets CII Because of Labeling Error | ONS Voice
Teva's struggling sterile plant hit with FDA warning letter - Skyland Analytics
Teva Issues Voluntary Nationwide Recall of One Lot of IDArubicin Hydrochloride Injection USP 5 mg/5 mL Due to the Presence of Particulate Matter | FDA
Teva Pharmaceuticals Receive Warning Letter from FDA – Parker Waichman LLP
Teva Receives FDA Warning Letter on China API Plant
TEVA Stock Pops 4% as Teva Receives FDA Approval | InvestorPlace
FDA warns eye drops may cause infection. Here's a list of 27 products to which the alert applies. - CBS News
Teva Pharmaceuticals on X: "Today, the FDA approved an interchangeable #biosimilar that may provide broader access to needed medicines for patients with autoimmune diseases. Along with our partner @alvotechpr, we are proud
FDA warning letter says Teva China plant has more work to do on API issues | Fierce Pharma
Generic Approvals Reshaping the SP Market | Anton Rx Report
ARS Pharma Shares Fall as FDA Declines to Approve Epinephrine Nasal Spray Neffy - WSJ
FDA warns fake Adderall ADD medication being sold online
Teva recalls one lot of leukemia med after finding particulates in vial | Fierce Pharma
FDA Nod to New MS Drug Spells Trouble for Teva - Haaretz Com - Haaretz.com
Teva confirms US FDA warning letter for Hangzhou, China API plant
Teva recalls one lot of IDArubicin Hydrochloride Injection USP
UPDATED: Teva's struggling sterile plant hit with FDA warning letter | Fierce Pharma
FDA Warning Letters: May 2023 Edition
